baber/WOPTO huggingface dataset:
Patent NZ-504137-A (NZ)
Title: Magnetically shielded container with a magnetically shielding yoke disposed about magnetic field homogenizing pole shoes
Inventor: AIDAM ELKE
IPC: G21F5/00
Filed: 1998-09-24
Abstract: A magnetically shielded container (1) having disposed in parallel opposed position on an axis (S) thereof magnetic field homogenizing pole shoes (1.1, 1.2), having disposed about the pole shoes a magnetically shielded yoke (2).  The pole shoes and yoke enclosing a magnetic chamber and the container further comprising magnetic field sources (2.4, 2.5) disposed about and radially distanced from the axis whereby there exists within the chamber substantially homogenous magnetic field oriented in the direction of the axis and whereby there is a usable volume within the chamber where the ratio of the magnetic field gradient in the direction transverse to the axis to the magnetic field has a value of no more than 1.5 x 10-3/cm.
Patent NZ-504456-A (NZ)
Title: A coffee machine assembly integrated into kitchen furniture so as to only partially occupy furniture space
Inventor: SCHMED ARTHUR
IPC: A47B77/08
Filed: 2000-05-10
Abstract: The arrangement (6) has a coffee machine (7) whose front region (10) is provided with operating and output elements. The fro region of the machine is an integral component of the front (3) of the kitchen unit (2) that extends only over part of the front the unit, whereby at least one accommodation region (8) is arranged next to and/or above and/or below the front region of the machine.
Patent NZ-504753-A (NZ)
Title: Histamine and serotonin binding molecules
Inventor: NUTTALL PATRICIA ANNE
IPC: A23L5/20
Filed: 1998-11-26
Abstract: Histamine and serotonin binding molecules that possess a binding site with the precise molecular configuration that is necessary to confer on the molecule a high affinity for histamine. Proteins, peptides and chemical compounds that possess this molecular configuration are able to bind to histamine with high affinity. These molecules may be used in the regulation of the action of histamine or serotonin, the detection and quantification or histamine or serotonin and in the treatment of diseases such as inflammation and allergies such as asthma, allergic rhinitis, atopic dermatitis or food and drug allergies. These molecules may also be used as components of vaccines directed against blood-sucking ectoparasites.
Patent NZ-506406-A (NZ)
Title: Compositions comprising Mycobacterium phlei DNA and methods for its use in the treatment of bladder cancer
Inventor: PHILLIPS NIGEL C
IPC: A61K31/70
Filed: 1998-12-22
Abstract: Use of a composition comprising Mycobacterium DNA (B-DNA) and a pharmaceutically acceptable carrier in the preparation of a medicament, wherein the medicament has anti-bladder cancer activity in an animal having bladder cancer, further wherein the B-DNA is not Mycobacterium bovis DNA.
Patent NZ-506648-A (NZ)
Title: Control of gene expression through introduction of synthetic tandem repeats to reduce translation of mRNA
Inventor: GRAHAM MICHAEL WAYNE
IPC: C12N9/10
Filed: 1999-03-19
Abstract: Disclosed is a method of modifying gene expression and to synthetic genes for modifying endogenous gene expression in a cell, tissue or organ of a transgenic organism, in particular a transgenic animal or plant. More particularly disclosed is the use of recombinant DNA technology to post-transcriptionally modify or modulate the expression of a target gene in a cell, tissue, organ or whole organism, thereby producing novel phenotypes. Novel synthetic genes and genetic constructs which are capable or repressing delaying or otherwise reducing the expression of an endogenous gene or a target gene in an organism when introduced thereto are also provided.
Patent NZ-510927-A (NZ)
Title: Immunodiagnostics using particle delivery methods
Inventor: SARPHIE DAVID FRANCIS
IPC: G01N33/58
Filed: 1999-09-03
Abstract: A method for assessing an allergic condition comprises: a) accelerating particles comprising an allergen into a target skin site in the individual and b) assessing the target site to determine the presence or absence of a localized skin immune reaction wherein the presence of a skin reaction is indicative of an allergic condition in the individual. A method for assessing a delayed type hypersensitivity (DTH) reaction in an individual and the use of an immunogenic moiety or an allergen in the manufacture of particulate compositions for assessing an immune response or an allergic condition is described. Preferably the immunogenic moiety is an allergen or an antigen selected from a pathogenic agent, a cancer antigen or a red blood cell Rh antigen
Patent NZ-511039-A (NZ)
Title: Volumizing hair care compositions containing siloxysilicates
Inventor: KOZUBAL CHERYL L
IPC: A61K8/896
Filed: 1999-10-07
Abstract: A volumising hair care composition comprising an MQ resin of formula (IA) with substituents defined within; wherein (x + y)/z equals 0.5-1.5, and the viscosity of the resin liquid is 1000-1000000 centipoise.
Patent NZ-514319-A (NZ)
Title: Proteinic pharmaceutical agent solubilized in aerosol propellant in a pressurized container
Inventor: MODI PANKAJ
IPC: A61K38/00
Filed: 2000-03-10
Abstract: A pressurized container contains a stable solubilized mixture of propellant, which is liquid under pressure, and an intermediate formulation, which comprises a pharmaceutical agent, water, first ingredient, second ingredient and at least one third ingredient.  The first ingredient is selected from the group consisting of glycerin and polyglycerin and mixtures thereof in an amount of from 1-50 wt./wt. % of the intermediate formulation. The second ingredient is selected from the group consisting of phenol, methyl phenol and mixtures thereof in an amount of from 1-20 wt./wt. % of the intermediate formulation. The third ingredient is selected from the group consisting of alkali metal C8 to C22 alkyl sulphate, polidocanol C6 to C40 alkyl ethers, trihydroxy sodium oxo-cholanyl glycines, polyoxethylene sorbitan ethers, alkyl-aryl polyether alcohols, hyaluronic acid and pharmaceutically suitable salts thereof, monoolein, triolein, lysine, polylysine, oleic acid, linoleic acid, linolenic acid, monooleates and laurates, glycolic acid, lactic acid, chenodeoxycholate, deoxycholate, chamomile extract, cucumber extract, borage oil and evening primrose oil and mixtures thereof, in an amount of from 1-50 wt./wt. % of the intermediate formulation. The total concentration of first, second and third ingredients is less than 90 wt./wt. % of the intermediate formulation. Also described is a process to making the stable aerosol pharmaceutical composition comprises solubilizing the propellant by a process comprising dissolving the proteinic agent in water and adjusting the pH to a level suitable for pharmaceutical use, mixing with the first ingredient, mixing with the second ingredient and subsequently mixing in the third ingredient. The intermediate formula is then charged to a pressurizable container and then the container is charged with a propellant. The pressurized container containing the stable solubilized mixture and intermediate formula is useful for administrating a proteinic agent bucally or into the lungs by spraying for the treatment of a medical condition.
Patent NZ-516310-A (NZ)
Title: Crystalline 1-methylcarbapenem compounds
Inventor: KAWAMOTO ISAO
IPC: A61K31/397
Filed: 2000-07-06
Abstract: 1-methylcarbapenem derivatives of formula (I), (I-2) and (1-3) are described. Pharmaceutical compositions comprising the derivatives can be used in the prevention or treatment of bacterial infections.
Patent NZ-517921-A (NZ)
Title: Antibiotic and acrylic polymer combination
Inventor: VOGT SEBASTIAN
IPC: A61K47/32
Filed: 2002-03-21
Abstract: An antibiotic(s)-polymer combination, which under physiological conditions guarantees the continous release of antibiotics over a period of several days and can be used in human and veterinary medicine.  The antibiotic(s)-polymer combination is characterized by the fact that in a homogeneous polymer mixture, consisting of one or more hydrophobic polymers from the groups of poly(methacrylic acid esters), the poly(acrylic acid esters) and the poly(methacrylic acid ester-co-acrylic acid esters) and one or more hydrophilic polymers from the group of polyethers, one or more slightly water-soluble antibiotics from the groups of aminoglycoside antibiotics, the lincosamide antibiotics, the tetracycline antibiotics and quinolone antibiotics, possibly an easily water-soluble antibiotic from the groups of aminoglycoside antibiotics, the lincosamide antibiotics and the tetracycline antibiotics and possibly one or more organic adjuvants are suspended and that this suspension forms a composite.
Patent NZ-518888-A (NZ)
Title: 4-pyridinyl-N-acyl-L-phenylalanines
Inventor: KAPLAN GERALD LEWIS
IPC: A61P25/00
Filed: 2000-11-29
Abstract: Compounds of formula below, that inhibit the interaction between á4-containing integrins and VCAM-1 and thus have use in treating chronic inflammatory diseases.
Patent NZ-521292-A (NZ)
Title: Sustained release ranolazine formulations
Inventor: WOLFF ANDREW A
IPC: A61K9/52
Filed: 2001-03-07
Abstract: Disclosed is the use of ranolazine for the manufacture of a sustained release pharmaceutical dosage form for treating a human patient suffering from a cardiovascular disease selected from arrhythmias, variant and exercise-induced angina, and myocardial infarction, said dosage form including at least 50% by weight ranolazine in no more than two tablets per dose to the human patient to maintain ranolazine plasma levels in the human patient at a minimum of 850 ng base/mL for at least 24 hours, said dose to be administered at a frequency selected from once, twice and three times over 24 hours.
Patent NZ-533275-A (NZ)
Title: 5, 6-Diaryl-pyrazine-2-amide derivatives as CB1 antagonists
Inventor: BERGGREN ANNA INGRID KRISTINA
IPC: A61P25/18
Filed: 2002-12-18
Abstract: Disclosed are compounds of formula (I), wherein: R1 and R2 are independently alkyl, (amino)alkyl-, optionally substituted carbocyclic, cycloalkylalkyl-, -(CH2)r(phenyl)s, naphthyl, anthracenyl, heterocyclic, 1-adamantylmethyl, -(CH2)tHet, or R1 is H and R2 is as defined above, X is CO or SO2, Y is absent or is NH optionally substituted by alkyl, and the remaining substituents are defined herein. The compounds are used in the manufacture of medicaments for use as CB1 modulators, in the treatment of diseases such as obesity.
Patent NZ-539626-A (NZ)
Title: Method of preparing moulded confectionery articles
Inventor: SANDERS NIGEL HUGH
IPC: A23G3/54
Filed: 2003-10-28
Abstract: A method of preparing moulded confectionery articles, comprising the steps of: (1) preparing a liquid candy composition which solidifies upon cooling, said liquid candy composition being at a first temperature; (2) preparing a liquid chocolate composition which solidifies upon cooling, said liquid chocolate composition being at a second temperature which is lower than said first temperature; (3) co-depositing the liquid candy composition and the liquid chocolate compositions in the moulds; and (4) cooling the moulded compositions in the moulds so as to solidify the moulded compositions to form moulded confectionery articles; wherein the liquid chocolate composition is subjected to a high shear of at least 100s<-1>, before being co-deposited in the moulds. This treatment enables the candy composition to be deposited into the moulds at a temperature which is higher than has heretofore been considered possible.
Patent NZ-540376-A (NZ)
Title: A shelf stable fluid comprising starch dispersed in an aqueous base
Inventor: MOOSER OSWALDO
IPC: A23L29/269
Filed: 2003-11-25
Abstract: A shelf stable fluid concentrated composition comprising starch dispersed in an aqueous base containing at least one dissolved aw depressing agent reducing aw to a value of less than 0.7, wherein the starch is in an unswollen state.
Patent NZ-541476-A (NZ)
Title: Medical data communication notification and messaging system and method
Inventor: SIMPSON THOMAS L C
IPC: G16H10/60
Filed: 2004-01-30
Abstract: A system and method for executing a notification process within a healthcare system. A remote device associated with a clinician is attached to a network and may send requests via the network to a central computer. The central computer may send a message to the remote device in response to the request.
Patent NZ-546888-A (NZ)
Title: Alcohol beverage bag with a neck moulding
Inventor: GRIMWADE STEPHEN J
IPC: B65D77/06
Filed: 2004-10-22
Abstract: This discloses a bag 10 suitable for containing an alcohol beverage. The bag includes at least two panels having adjacently positioned edges 14 16 forming at least one seam 18, the seam 18 having a joined seam portion 18 where the adjacently positioned edges 14 16 of the panels are joined together, and an open seam portion 30 where the adjacently positioned edges of the panels are not joined together; and, a bag neck moulding extending through the open seam portion. The bag neck moulding is secured in a sealing relation with the panels of the bag at the open seam portion, and supports a valve 47 accessible for operation from outside the bag and a spear 50 extending into the bag through which the beverage may pass. The bag neck moulding has a peripheral side wall 52 having a circumference greater in length than the adjacently positioned edges of the panels extending along the open seam.
Patent NZ-549626-A (NZ)
Title: Separate trading of registered interest and principal of securities system, method and computer program product
Inventor: ARNOTT ROBERT D
Filed: 2005-02-04
Abstract: A method and system for generating a correlated investment is provided. The method includes the steps of aligning a net asset value of a correlated investment with a present value of a future liability by matching a duration of the correlated investment to a duration of the future liability and changing the net asset value of the correlated investment in a highly correlated manner with a change in the present value of the future liability where the duration of the future liability is greater than the duration of a longest available bond issued by a sovereign. A correlating investment using an original investment amount and leverage funds can then be generated.
Patent NZ-550006-A (NZ)
Title: Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of FAAH enzyme inhibitors
Inventor: ABOUABDELLAH AHMED
IPC: C07D471/04
Filed: 2005-02-25
Abstract: The disclosure relates to enzyme inhibitors and their use in the treatment and therapy of a wide variety of diseases and degenerative conditions. More particularly, it is directed towards the use of aryl and heteroaryl-piperidinecarboxylate derivatives of formula (I), processes for their preparation and methods of use thereof as fatty acid amido hydrolase (FAAH) enzyme inhibitors in the treatment of arthritis, heart disease, cancer and the like and to their application in a wide variety of therapeutic regimens such as for the treatment of pain, inflammation, neurodegenerative diseases, etc.
Patent NZ-551011-A (NZ)
Title: Mobile medical facility
Inventor: BLACKWELL THOMAS H
IPC: B60P3/14
Filed: 2005-05-09
Abstract: A mobile medical treatment facility capable of being transported over the roadways and treating a plurality of patients suffering from a range of conditions is disclosed. The medical facility includes a trailer (11) with at least two opposing slide outs (30, 40, 50) where together the slide outs define a floor area of the trailer. The slide outs have at least two configurations. In the first configuration the floor area of the trailer is reduced to allow for the transporting of the trailer. In the second configuration the floor area supports a first patient area configured to provide general care to a number of patients and a second patient area configured to provide surgical care to at least one patient. Additionally, in the second configuration, the first patient area includes two rows of patient treatment bays with one or more privacy partitions dividing each bay.
Patent NZ-555666-A (NZ)
Title: Storage bag with fluid separator
Inventor: BERGMAN CARL L
IPC: B65D85/07
Filed: 2005-12-16
Abstract: An open storage bag 100 comprises two flexible sidewalls 102, 104 with their first side edges 110, second parallel side edges 112 and bottom edges 114 joined to provide an interior volume 106. Both side walls 102, 104 have closure strips 126, 128 attached next to the opening. A separator 132/134 with a one-way valve 130 in the centre is fixed to one sidewall 102. The separator 132/134 can be adjusted between a collapsed position where the position of the separator 132/134 and the valve 130 coincide with that of the sidewall 102 to which they are attached, and an expanded position where the expanded separator 132/134 raises the valve 130 away from the sidewall 102. The separator 132/134 removes fluid from the air evacuated from the interior volume 106 of the bag 100 through the valve 130 by allowing the fluid to separate under the effect of gravity and return to the interior volume 106 of the bag 100. This effect prevents the evacuation of fluid from the bag that may contaminate the valve 130 or the outer surface of the bag 100.
Patent NZ-556075-A (NZ)
Title: Change management
Inventor: PARRY WARREN JOHN
IPC: G06F17/18
Filed: 2005-12-20
Abstract: A system and a computer generated analytical tool for assessing a state of an entity are disclosed. The system comprises a data generator for generating entity data for the entity to be analysed; comprises the computer generated analytical tool into which the entity data is input to position and track progress of the entity and an output data set produced from the computer generated analytical tool. The entity data includes at least one variable applicable to the entity and the at least one variable comprising a plurality of drivers. The computer generated analytical tool comprises an array of cells arranged in at least one of a two dimensional map and a three dimensional mapping. Each cell contains a subset of reference data and the reference data within each cell provides a measure of each driver related to the state of a community of which the entity forms a part and the positioning of the cells relative to one another being governed by the inter-relationship of the reference data contained in the cells. The array of reference data is obtained by performing cluster analysis on source data, such source data relating to the state of the community. The output data set is used in an analysis of the entity.
Patent NZ-556571-A (NZ)
Title: Power tool including spindle lock mechanism
Inventor: GALLAGHER WILLIAM F
Filed: 2006-05-05
Abstract: A power tool includes a motor disposed within a housing, a gear case connected to the housing, a gear disposed within the gear case and arranged to be driven by the motor, a wheel spindle extending from the gear case and arranged to be driven by the gear and a spindle locking member disposed on the wheel spindle. The spindle locking member has a plurality of grooves and ramps formed on a side thereof and a lock mechanism disposed within the gear case engageable with the spindle locking member, the lock mechanism has a portion extending out from the gear case to be engageable by a user for moving the lock mechanism between a first position and a second position. The power tool is configured such that when the lock mechanism is in its second position, the lock mechanism fits within one of the plurality of grooves of the spindle locking member. When the lock mechanism is in its first position, the lock mechanism does not engage the spindle locking member, and the lock mechanism is adapted to slide within a groove formed in the gear case when the lock mechanism is moved between its first position and its second position. The groove is oriented in a generally diagonal manner with respect to the axis of rotation of the spindle and an axis which is perpendicular thereto.
Patent NZ-556662-A (NZ)
Title: Transport device and method for transporting fluid with expandable fluid tank removable from a vehicle cargo area
Inventor: ALBERS HENDRIKUS JOHANNES MARIA
IPC: B60P3/42
Filed: 2006-01-18
Abstract: The present disclosure relates to a transport device (1) for transporting loose cargo and fluid, comprising: - an elongate loading floor (5) on which loose cargo can be placed; - a fluid tank (10) to be fixed releasably to the loading floor (5) and in which fluid can be stored, wherein the tank (10) can be folded in longitudinal direction over the loading floor (5) between a collapsed state in which the tank (10) takes up a minimum loading floor area, to enable transport of a relatively large quantity of loose cargo, and an expanded state to enable transport of a relatively large amount of fluid.
Patent NZ-562559-A (NZ)
Title: Stable nanoparticle formulations smaller than 1000 nm without the use of any surface modifier or stabilizzer absorbed onto the surface of the particles
Inventor: ABU-IZZA KHAWLA ABDULLAH
IPC: A61K9/14
Filed: 2006-05-03
Abstract: Disclosed is a nanoparticle pharmaceutical formulation comprising a poorly soluble drug substance having an average particle size of less than about 1000 nm, a solid or semisolid dispersion vehicle, and optionally a non-surface modifying excipient and without have a surface modifier or stabilizer absorbed onto the surface of the drug particles. Further disclosed are uses of said formulations and preparation processes thereof.
Patent NZ-564121-A (NZ)
Title: Fluid flow controller
Inventor: DANA YOSSI
IPC: F16K15/02
Filed: 2006-06-14
Abstract: A magnetic flow controller 10 transforms a slow reduction in pressure of fluid flow over time to a measurable fluid flow. Once a threshold pressure differential is reached, the flow passage 12, 32 through the flow controller opens rapidly to a relatively large opening, thereby generating a volume of fluid at high flux flowing through the passage, particularly to permit the measurement of the volume of fluid in a conventional flow meter. The flow controller includes a stop member 18 mounted across the inlet 14 and a displaceable member 30 which is attracted toward stop member 18 by an included magnet 34 to close and seal the flow passage when the displaceable member 30 engages the seal 22. As a pressure differential builds up between the inlet 18 and the outlet 16 of the flow passage the displaceable member 30 is first accelerated through the flow passage toward the outlet against the magnetic force whilst still sealing the passage until it reaches a desired speed at which position the sealing engagement between the displaceable member and the seal is released to unseal the flow passage to allow flow of fluid through the passage.
Patent NZ-568011-A (NZ)
Title: Conversion device for connecting spike to valve of container for medical applications
Inventor: RICHMOND FRANK M
IPC: A61M39/22
Filed: 2006-10-19
Abstract: A conversion device is provided that is effective for converting/adapting a spiked medical device/disposable to a valve/port on a container, such as for example a reflux-valve port on a container. The conversion device includes an attachment feature selected from a specified group such as male of female connector, cannula, male or female, luer and others. At least one membrane port is on an end opposite the attachment feature, and an intermediate structure is disposed between the attachment feature and membrane port.